Cargando…
Corneal Endothelial Cell Loss in Patients After Minimally Invasive Glaucoma Surgery: Current Perspectives
Minimally invasive glaucoma surgery (MIGS) is a rapidly expanding category of surgical glaucoma treatment options that offer a superior safety profile compared with traditional approaches for reducing intraocular pressure. However, MIGS may cause corneal endothelial cell loss; therefore, it has been...
Autores principales: | Obuchowska, Iwona, Konopińska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148582/ https://www.ncbi.nlm.nih.gov/pubmed/35642179 http://dx.doi.org/10.2147/OPTH.S359305 |
Ejemplares similares
-
Evaluation of the Effect of the First Generation iStent on Corneal Endothelial Cell Loss—A Match Case-Control Study
por: Konopińska, Joanna, et al.
Publicado: (2021) -
Changes to glaucoma surgery patterns during the coronavirus disease 2019 pandemic: a shift towards less invasive procedures
por: Dub, Natalia, et al.
Publicado: (2022) -
Evaluation of the Efficacy and Safety of Canaloplasty and iStent Bypass Implantation in Patients with Open-Angle Glaucoma: A Review of the Literature
por: Gołaszewska, Kinga, et al.
Publicado: (2021) -
Fear and Anxiety Associated with Cataract Surgery Under Local Anesthesia in Adults: A Systematic Review
por: Obuchowska, Iwona, et al.
Publicado: (2021) -
First-Generation iStent Bypass Implantation versus ab Externo Canaloplasty Combined with Phacoemulsification in Patients with Primary Open Angle Glaucoma—12-Month Follow-Up
por: Gołaszewska, Kinga, et al.
Publicado: (2023)